chr17-10642813-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002470.4(MYH3):​c.1581+13A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.716 in 1,613,388 control chromosomes in the GnomAD database, including 423,631 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.63 ( 32086 hom., cov: 31)
Exomes 𝑓: 0.72 ( 391545 hom. )

Consequence

MYH3
NM_002470.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.895

Publications

12 publications found
Variant links:
Genes affected
MYH3 (HGNC:7573): (myosin heavy chain 3) Myosin is a major contractile protein which converts chemical energy into mechanical energy through the hydrolysis of ATP. Myosin is a hexameric protein composed of a pair of myosin heavy chains (MYH) and two pairs of nonidentical light chains. This gene is a member of the MYH family and encodes a protein with an IQ domain and a myosin head-like domain. Mutations in this gene have been associated with two congenital contracture (arthrogryposis) syndromes, Freeman-Sheldon syndrome and Sheldon-Hall syndrome. [provided by RefSeq, Jul 2008]
MYHAS (HGNC:50609): (myosin heavy chain gene cluster antisense RNA) Predicted to enable primary miRNA binding activity. Predicted to be involved in response to muscle activity and skeletal muscle fiber development. Predicted to act upstream of or within with a positive effect on gene expression. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 17-10642813-T-G is Benign according to our data. Variant chr17-10642813-T-G is described in ClinVar as Benign. ClinVar VariationId is 258671.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.764 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH3NM_002470.4 linkc.1581+13A>C intron_variant Intron 15 of 40 ENST00000583535.6 NP_002461.2 P11055Q5GJ67
MYH3XM_011523870.4 linkc.1581+13A>C intron_variant Intron 15 of 40 XP_011522172.1 P11055
MYH3XM_011523871.3 linkc.1581+13A>C intron_variant Intron 15 of 40 XP_011522173.1 P11055
MYH3XM_047436127.1 linkc.1581+13A>C intron_variant Intron 17 of 42 XP_047292083.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH3ENST00000583535.6 linkc.1581+13A>C intron_variant Intron 15 of 40 5 NM_002470.4 ENSP00000464317.1 P11055
MYHASENST00000579914.2 linkn.705+28936T>G intron_variant Intron 4 of 4 4
MYHASENST00000584139.2 linkn.1041+28936T>G intron_variant Intron 7 of 8 3

Frequencies

GnomAD3 genomes
AF:
0.632
AC:
95718
AN:
151540
Hom.:
32078
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.421
Gnomad AMI
AF:
0.792
Gnomad AMR
AF:
0.590
Gnomad ASJ
AF:
0.731
Gnomad EAS
AF:
0.371
Gnomad SAS
AF:
0.592
Gnomad FIN
AF:
0.723
Gnomad MID
AF:
0.592
Gnomad NFE
AF:
0.769
Gnomad OTH
AF:
0.633
GnomAD2 exomes
AF:
0.648
AC:
162880
AN:
251420
AF XY:
0.660
show subpopulations
Gnomad AFR exome
AF:
0.419
Gnomad AMR exome
AF:
0.485
Gnomad ASJ exome
AF:
0.730
Gnomad EAS exome
AF:
0.361
Gnomad FIN exome
AF:
0.731
Gnomad NFE exome
AF:
0.763
Gnomad OTH exome
AF:
0.687
GnomAD4 exome
AF:
0.725
AC:
1059165
AN:
1461730
Hom.:
391545
Cov.:
120
AF XY:
0.723
AC XY:
525940
AN XY:
727168
show subpopulations
African (AFR)
AF:
0.405
AC:
13566
AN:
33470
American (AMR)
AF:
0.498
AC:
22255
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.728
AC:
19032
AN:
26132
East Asian (EAS)
AF:
0.355
AC:
14074
AN:
39696
South Asian (SAS)
AF:
0.604
AC:
52111
AN:
86254
European-Finnish (FIN)
AF:
0.737
AC:
39384
AN:
53420
Middle Eastern (MID)
AF:
0.594
AC:
3428
AN:
5768
European-Non Finnish (NFE)
AF:
0.768
AC:
853419
AN:
1111904
Other (OTH)
AF:
0.694
AC:
41896
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
21192
42385
63577
84770
105962
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20196
40392
60588
80784
100980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.631
AC:
95751
AN:
151658
Hom.:
32086
Cov.:
31
AF XY:
0.625
AC XY:
46292
AN XY:
74106
show subpopulations
African (AFR)
AF:
0.421
AC:
17333
AN:
41218
American (AMR)
AF:
0.590
AC:
8982
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.731
AC:
2539
AN:
3472
East Asian (EAS)
AF:
0.371
AC:
1897
AN:
5108
South Asian (SAS)
AF:
0.592
AC:
2843
AN:
4804
European-Finnish (FIN)
AF:
0.723
AC:
7641
AN:
10568
Middle Eastern (MID)
AF:
0.588
AC:
173
AN:
294
European-Non Finnish (NFE)
AF:
0.769
AC:
52284
AN:
67950
Other (OTH)
AF:
0.637
AC:
1337
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1652
3303
4955
6606
8258
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.706
Hom.:
100397
Bravo
AF:
0.606
Asia WGS
AF:
0.500
AC:
1742
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Freeman-Sheldon syndrome Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Contractures, pterygia, and variable skeletal fusions syndrome 1B Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arthrogryposis, distal, type 2B3 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Distal arthrogryposis type 2B1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.12
DANN
Benign
0.34
PhyloP100
-0.90
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2285468; hg19: chr17-10546130; COSMIC: COSV56868340; API